Evogene Ltd.
corporate_fare Company Profile
Evogene Ltd. (NASDAQ:EVGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 34 items for EVGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-11, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for EVGN spans SCHEDULE 13D/A, 6-K, 4, SCHEDULE 13D.
Recent high-impact activity:
- Activist Group Launches $0.55/Share Tender Offer for 25% of Evogene
- Evogene Shareholders Approve Board Slate, Ending Activist Proxy Fight
- Evogene Reports Q2 and First Half 2026 Results Amid Activist Board Fight
- Evogene Q2 Loss Narrows to $1.8M; Cash Burn Cut to $8.5–$9.5M
- Activist Group Raises Evogene Stake to 19.35% with $350K in New Purchases
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for EVGN, detected from its recent SEC filings · based on capital-structure filings through 2026-07-17.
ATM Upsized to $3.3M · $1.75M Already Sold
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
EVGN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.